Free Trial

Northland Capmk Analysts Boost Earnings Estimates for Enovix

Enovix logo with Energy background

Enovix Corporation (NASDAQ:ENVX - Free Report) - Stock analysts at Northland Capmk lifted their Q1 2026 EPS estimates for Enovix in a research note issued to investors on Monday, July 7th. Northland Capmk analyst G. Richard now forecasts that the company will earn ($0.20) per share for the quarter, up from their previous forecast of ($0.28). The consensus estimate for Enovix's current full-year earnings is ($1.01) per share. Northland Capmk also issued estimates for Enovix's Q2 2026 earnings at ($0.21) EPS, Q3 2026 earnings at ($0.21) EPS, Q4 2026 earnings at ($0.21) EPS and FY2026 earnings at ($0.85) EPS.

ENVX has been the topic of several other reports. TD Securities cut their price target on shares of Enovix from $10.00 to $7.00 and set a "hold" rating on the stock in a report on Thursday, May 1st. Craig Hallum reaffirmed a "buy" rating and issued a $15.00 price target (up from $12.00) on shares of Enovix in a report on Tuesday. B. Riley cut their price target on shares of Enovix from $17.00 to $12.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. Cowen reaffirmed a "hold" rating on shares of Enovix in a report on Tuesday. Finally, JPMorgan Chase & Co. lowered their target price on shares of Enovix from $10.00 to $9.00 and set an "overweight" rating for the company in a research note on Thursday, May 1st. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $17.09.

Get Our Latest Research Report on Enovix

Enovix Stock Up 2.1%

ENVX traded up $0.28 during trading on Wednesday, hitting $13.72. The company had a trading volume of 10,774,866 shares, compared to its average volume of 5,946,790. The company has a market cap of $2.63 billion, a PE ratio of -10.64 and a beta of 2.09. The business has a 50-day moving average of $8.42 and a 200-day moving average of $9.01. The company has a debt-to-equity ratio of 0.71, a current ratio of 4.68 and a quick ratio of 4.49. Enovix has a 1-year low of $5.27 and a 1-year high of $18.68.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ENVX. Coppell Advisory Solutions LLC acquired a new position in Enovix during the 4th quarter valued at about $27,000. Stone House Investment Management LLC acquired a new position in Enovix during the 1st quarter valued at about $37,000. Sava Infond d.o.o. acquired a new position in Enovix during the 4th quarter valued at about $43,000. Parallel Advisors LLC boosted its stake in Enovix by 103.8% during the 1st quarter. Parallel Advisors LLC now owns 7,557 shares of the company's stock valued at $55,000 after purchasing an additional 3,849 shares during the period. Finally, Hollencrest Capital Management boosted its stake in Enovix by 61.4% during the 4th quarter. Hollencrest Capital Management now owns 5,256 shares of the company's stock valued at $57,000 after purchasing an additional 2,000 shares during the period. 50.92% of the stock is owned by institutional investors and hedge funds.

Enovix declared that its board has initiated a share repurchase plan on Wednesday, July 2nd that permits the company to buyback $60.00 million in shares. This buyback authorization permits the company to purchase up to 3.1% of its shares through open market purchases. Shares buyback plans are generally a sign that the company's leadership believes its stock is undervalued.

About Enovix

(Get Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Read More

Earnings History and Estimates for Enovix (NASDAQ:ENVX)

Should You Invest $1,000 in Enovix Right Now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines